Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders

Cognitive impairment is a shared abnormality between type 2 diabetes mellitus (T2DM) and many neurodegenerative and neuropsychiatric disorders, such as Alzheimer’s disease (AD) and schizophrenia. Emerging evidence suggests that brain insulin resistance plays a significant role in cognitive deficits,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Cao, Ting, Li, NaNa, Zeng, Cuirong, Zhang, Shuangyang, Wu, Xiangxin, Zhang, Bikui, Cai, Hualin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182376/
https://www.ncbi.nlm.nih.gov/pubmed/34108878
http://dx.doi.org/10.3389/fphar.2021.667874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182376/
https://www.ncbi.nlm.nih.gov/pubmed/34108878
http://dx.doi.org/10.3389/fphar.2021.667874

Ejemplares similares